Earning Release

Aemetis Reports First Quarter 2025 Financial Results

May 8, 2025

California Ethanol passes $2 billion cumulative revenue milestone Aemetis Biogas increased sales by 10,100 MMBtu compared with same quarter last year Sales of investment tax credits resulted in cash proceeds of $19.0 million during Q1 2025 India Biodiesel received letters of intent in April for an aggregate of $31 million of biodiesel sales to OMCs for delivery in May, June and July of 2025 CUPERTINO, Calif., May 8, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas...

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

May 7, 2025

IRVINE, Calif., May 7, 2025 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results at 2:00 p.m. PT that same day. Registration for the live webinar, which will discuss financial results and include Q&A, is required at the following link: Oncocyte Q1...

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

Apr 30, 2025

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 30, 2025 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it will release its first quarter 2025 financial results on Monday, May 12, 2025, and will host a conference call and webcast at 4:30 PM ET. The webcast will feature an overview of the...

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

Apr 14, 2025

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter of profitability Preliminary Q4 2024 Adjusted EBITDA of $11.1 Million Financial Results Conference Call and Webcast to be held on April 14, 2025 at 4:30 pm ET POMPANO BEACH, FL, April 14, 2025 - PRISM MediaWire - BioStem Technologies, Inc....

AmpliTech Reports FY 2024 Financial Results

Apr 1, 2025

Working Capital of $27 Million; Over $19 Million in Cash; Zero Debt 5G Division’s ORAN Products Positioned for Strong FY 2025 Performance HAUPPAUGE, N.Y., April 01, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG), a leading designer, developer, and manufacturer of advanced signal-processing components for satellite, 5G, and other communication networks, including complete 5G/6G system design, and a global distributor of packaging and lid solutions for integrated circuit assembly,...

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Mar 24, 2025

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity raises Advanced science in transplant; achieved Medicare claims expansion IRVINE, Calif., March 24, 2025 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to...

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

Jan 13, 2025

Reports Third Consecutive Quarter of Revenue above $5 million First Nine Months Revenue Growth of 3% YOY Backlog Remains Strong at $10.6 Million Provides Guidance for Revenue of over $20 million and Continued Profitability for Fiscal Year 2025 MILTON, N.Y., January 13, 2025 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and nine months of fiscal year 2025,...

AmpliTech Group Reports 2.8M revenue, 1.3M Gross profits, 47% Gross Margins

Nov 15, 2024

Hauppauge, NY, November 15, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its financial results for the third quarter ended September 30, 2024. Q3 2024 Highlights...

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Nov 12, 2024

Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phase FDA pre-submission process for approval of kitted clinical test is underway IRVINE, Calif., Nov. 12, 2024 - PRISM MediaWire - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today published the following letter to shareholders in conjunction with its third...

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

Nov 12, 2024

Company reports third sequential quarter of record growth, contributing to a record total of $199.0 million in revenue for the first nine-months of 2024 Achieves third consecutive quarter of positive GAAP net income of $6.8 million or $0.42 per share. Generated Q3 2024 Adjusted EBITDA of $9.9 million Financial Results Conference Call and Webcast on Tuesday, November 12, 2024, at 4:30 pm ET POMPANO BEACH, FL, November 12, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM) (the...

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Oct 15, 2024

Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of $11.7 Million First Half Revenue Growth of 10% YOY, First Half Net Income Growth of 13% YOY Expects Continued Revenue Growth for Full Fiscal Year 2025 Conference Call Today at 10:00 am ET MILTON, N.Y., October 15, 2024 – PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second...

NEWSROOM

Aemetis Reports First Quarter 2025 Financial Results

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

AmpliTech Reports FY 2024 Financial Results

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

AmpliTech Group Reports 2.8M revenue, 1.3M Gross profits, 47% Gross Margins

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Contact Us